U.S. Contraceptive Market to Surpass Valuation of USD 12,423.5 Million by 2032 | SkyQuest Technology

U.S. Contraceptive Market to Surpass Valuation of USD 12,423.5 Million by 2032 | SkyQuest Technology

SkyQuest projects that the Global U.S. Contraceptive Market size will reach a value of USD 12,423.5 Million by 2032, with a CAGR of 4.7% during the forecast period (2025-2032). The US contraceptive market is an essential component of the country’s healthcare sector due to the growing concern of family planning and oral contraceptive pills, the availability of reproductive health services and the enhancements in contraceptive technologies. This market plays crucial roles in offering proper contraception measures, preventing unwanted pregnancies and assisting people in their reproductive decision making process. One of the main drivers for this market is the shift towards the increased use of LARCs, like IUDs and implants. According to the Guttmacher Institute, relying on the data of USA, the percentage of women, aged 15–44, who use LARCs has increased from 2.4 in 2002 to more than 10 in recent years thus indicating that women shifted toward more effective and least demanding contraceptives.

Browse in-depth TOC on the "U.S. Contraceptive Market"

Pages – 147

Tables – 3

Figures – 36

U.S. Contraceptive Market Overview:

Report Coverage

Details

Market Revenue in 2024

USD 8,906.4 Million

Estimated Value by 2032

USD 12,423.5 Million

Growth Rate

Poised to grow at a CAGR of 4.7%

Forecast Period

2025–2032

Forecast Units

Value (USD Million)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Type, Age Group, Distribution Channel and Region

Geographies Covered

United States

Report Highlights

Growing education on reproductive health and family planning drives demand for contraceptives.

Key Market Opportunities

Growth of telehealth services provides opportunities for broader access to contraceptive methods.

Key Market Drivers

Innovation in non-hormonal and long-acting reversible contraceptives (LARCs) increases consumer interest.

Contraceptive Devices Dominate U.S. Market and Are Set for Continued Growth

Contraceptive devices, including intrauterine devices (IUDs), implants, and condoms, currently lead the U.S. contraceptive market, commanding a substantial 64.76% market share. This segment is expected to experience a robust compound annual growth rate (CAGR) of 4.7%. The growing preference for long-acting reversible contraceptives (LARCs), such as IUDs and implants, is driving the expansion of this segment. These devices are favored for their long-term effectiveness, low maintenance, and availability of non-hormonal options. With ongoing innovations in design and advancements in technology, the market share of contraceptive devices is set to rise, making this segment the fastest-growing in the U.S. contraceptive market.

Offline Sales Lead the Charge in the U.S. Contraceptive Market, Driving Consumer Confidence and Accessibility

The offline segment maintains a dominant position in the U.S. Contraceptive Market, holding the majority of the market share. This segment primarily consists of sales through physical retail locations such as pharmacies, drugstores, and supermarkets, allowing consumers to directly purchase contraceptive products. The offline market benefits from established consumer trust in physical stores and the convenience of immediate product access. Furthermore, healthcare professionals and clinics continue to play a key role in recommending and distributing contraceptives, strengthening the offline segment’s prominence. This established sales channel is expected to remain a significant contributor to the market in the coming years.

U.S. Contraceptive Market Booms with Innovation, Accessibility, and Evolving Consumer Preferences

The U.S. Contraceptive Market is experiencing steady growth, fueled by increased awareness of reproductive health and the availability of advanced contraceptive options. Our study shows the market is divided into hormonal and non-hormonal methods, with hormonal contraceptives, such as oral pills, implants, and IUDs, capturing the largest share. A notable trend is the growing preference for long-acting reversible contraceptives (LARCs), which offer convenience and higher efficacy rates. The demand for contraceptives is also shaped by government policies, healthcare accessibility, and societal acceptance, with family planning services playing a pivotal role in promoting usage. Additionally, the increasing focus on women’s health and the rise of over-the-counter options are expected to further boost market growth. Leading players in the U.S. Contraceptive Market are prioritizing product innovation and strategic partnerships to meet diverse consumer needs and expand their market footprint.

U.S. Contraceptive Market Insight

Drivers:

  1. Public health initiatives and insurance coverage for contraceptives boost market accessibility.
  2. Increasing focus on women’s health and reproductive rights propels the Contraceptive Market.
  3. Remote consultations and prescriptions for contraceptives have increased access and convenience.

Restraints:

  1. High costs and lack of insurance coverage limit access for low-income populations.
  2. Conservative views in some regions may hinder widespread adoption of contraceptives.
  3. Negative perceptions of hormonal contraceptives due to side effects can deter usage.

Prominent Players in U.S. Contraceptive Market

  • Merck & Co., Inc
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • HLL Lifecare Ltd
  • Viatris
  • Amneal Pharmaceuticals
  • The Population Council
  • AbbVie Inc.

Key Questions Answered in Global U.S. Contraceptive Market Report

  • What impact do government policies and healthcare accessibility have on contraceptive usage in the U.S.?
  • How is the demand for long-acting reversible contraceptives (LARCs) shaping the market trends?
  • Who are the major players in the U.S. Contraceptive Market and what strategies are they employing?

This report provides the following insights:

  • Analysis of key drivers (Integration of Telehealth Services, and Increasing Awareness of Family Planning), restraints (Socio-Economic Barriers, and Cultural & Religious Opposition), opportunities (Expanding Access to Remote Healthcare, and Innovation in Non-Hormonal Methods), and challenges (Navigating State-Level Legislation, and Disparities in Access to Healthcare) influencing the growth of U.S. Contraceptive Market.
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the U.S. Contraceptive Market.
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the U.S. Contraceptive Market.
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia-Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: [email protected]

Visit Our Website: https://www.skyquestt.com/

People Also Read